These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34788181)

  • 1. Eyedrop vaccination: an immunization route with promises for effective responses to pandemics.
    Lee JS; Yoon S; Han SJ; Kim ED; Kim J; Shin HS; Seo KY
    Expert Rev Vaccines; 2022 Jan; 21(1):91-101. PubMed ID: 34788181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity.
    Kim ED; Han SJ; Byun YH; Yoon SC; Choi KS; Seong BL; Seo KY
    PLoS One; 2015; 10(9):e0137608. PubMed ID: 26355295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eye mucosa: an efficient vaccine delivery route for inducing protective immunity.
    Seo KY; Han SJ; Cha HR; Seo SU; Song JH; Chung SH; Kweon MN
    J Immunol; 2010 Sep; 185(6):3610-9. PubMed ID: 20709955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen.
    Jones DI; Pollara JJ; Johnson-Weaver BT; LaBranche CC; Montefiori DC; Pickup DJ; Permar SR; Abraham SN; Maddaloni M; Pascual DW; Staats HF
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of injectable human papilloma virus vaccine administered as eyedrops.
    Kim J; Kim ED; Shin HS; Han SJ; Jamiyansharav M; Yoon SC; Lee JS; Seo KY
    Vaccine; 2023 Jan; 41(1):92-100. PubMed ID: 36402660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eyedrop Vaccination Induced Systemic and Mucosal Immunity against Influenza Virus in Ferrets.
    Yoon S; Kim ED; Song MS; Han SJ; Park TK; Choi KS; Choi YK; Seo KY
    PLoS One; 2016; 11(6):e0157634. PubMed ID: 27333331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection from hemolytic uremic syndrome by eyedrop vaccination with modified enterohemorrhagic E. coli outer membrane vesicles.
    Choi KS; Kim SH; Kim ED; Lee SH; Han SJ; Yoon S; Chang KT; Seo KY
    PLoS One; 2014; 9(7):e100229. PubMed ID: 25032703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outer membrane vesicle-based intranasal vaccines.
    Van der Ley P; Schijns VE
    Curr Opin Immunol; 2023 Oct; 84():102376. PubMed ID: 37598549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza.
    Pedersen G; Cox R
    Hum Vaccin Immunother; 2012 May; 8(5):689-93. PubMed ID: 22495121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal formulations: promising strategy to deliver vaccines.
    Riese P; Sakthivel P; Trittel S; Guzmán CA
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1619-34. PubMed ID: 24962722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal and systemic immune responses induced by a single time vaccination strategy in mice.
    González Aznar E; Romeu B; Lastre M; Zayas C; Cuello M; Cabrera O; Valdez Y; Fariñas M; Pérez O
    Can J Microbiol; 2015 Aug; 61(8):531-8. PubMed ID: 26140382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections.
    Calzas C; Chevalier C
    Front Immunol; 2019; 10():1605. PubMed ID: 31379823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New routes of administration: epidermal, transcutaneous mucosal ways of vaccination].
    Denis F; Alain S; Ploy MC
    Med Sci (Paris); 2007 Apr; 23(4):379-85. PubMed ID: 17433227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal responses to parenteral and mucosal vaccines.
    Kaul D; Ogra PL
    Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses.
    Torrieri-Dramard L; Lambrecht B; Ferreira HL; Van den Berg T; Klatzmann D; Bellier B
    Mol Ther; 2011 Mar; 19(3):602-11. PubMed ID: 20959813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal vaccination of recombinant H5N1 HA1 proteins fused with foldon and Fc induces strong mucosal immune responses with neutralizing activity: Implication for developing novel mucosal influenza vaccines.
    Yu F; Li Y; Guo Y; Wang L; Yang J; Zhao G; Zhou Y; Du L; Jiang S
    Hum Vaccin Immunother; 2015; 11(12):2831-8. PubMed ID: 26260706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal and systemic responses of immunogenic vaccines candidates against enteric Escherichia coli infections in ruminants: A review.
    Lawan A; Jesse FFA; Idris UH; Odhah MN; Arsalan M; Muhammad NA; Bhutto KR; Peter ID; Abraham GA; Wahid AH; Mohd-Azmi ML; Zamri-Saad M
    Microb Pathog; 2018 Apr; 117():175-183. PubMed ID: 29471137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant.
    Rask C; Fredriksson M; Lindblad M; Czerkinsky C; Holmgren J
    APMIS; 2000 Mar; 108(3):178-86. PubMed ID: 10752686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
    Nagai M; Moriyama M; Ichinohe T
    mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-protective immunity against influenza virus infections induced by intranasal vaccination together with a TLR3-mucosal adjuvant.
    Ainai A; Tashiro M; Hasegawa H
    Hum Vaccin; 2011; 7 Suppl():174-82. PubMed ID: 21321485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.